jrnls.org logo
Submit

BROWSE ALL JOURNALS

SEE ALL 19 JOURNALS
International Journal of Pharmaceutical InvestigationNOW IN
Review

Compensation to clinical trial participants in India: A gap analysis

Mohd Urooj1★, Gulam Mohammed Husain1, Mohammad Ahmed Khan1, Munawwar Husain Kazmi1★ Corresponding author

  1. 1Department of Pharmacology, Central Research Institute of Unani Medicine, Under CCRUM, Ministry of AYUSH Government of India, Hyderabad, Telangana, INDIA.

CORRESPONDENCE

Mohd Urooj

Department of Pharmacology, Central Research Institute of Unani Medicine, Under CCRUM, Ministry of AYUSH Government of India, Hyderabad, Telangana, INDIA.

qaziurooj@gmail.com

Volume 7, Issue 2 · pp. 41–46 · PUBLISHED · DOI: 10.4103/jphi.JPHI_31_17

View on IJPI original site ↗

ABSTRACT

The recent amendments notified by the Government of India, for conducting clinical trial, is greatly appreciable as promoting safety and well‑being of human subjects. These rules clearly state that medical management of injuries in clinical trials is mandatory, and clinical trial‑related injury or death needs to be compensated over and above the medical management. These rules need to be reconsidered for simplification and better understanding of issues regarding compensation. There is a need of clarity at some points which should be discussed with all stakeholders for better understanding of current regulations. In our view, attention must also be given to academic investigators, during discussion to promote availability of cost‑effective treatment in India.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Urooj, M., Husain, G. M., Khan, M. A., & Kazmi, M. H. (). Compensation to clinical trial participants in India: A gap analysis. International Journal of Pharmaceutical Investigation, 7(2), 41–46. https://doi.org/10.4103/jphi.JPHI_31_17